(19)
(11) EP 4 771 144 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24857554.0

(22) Date of filing: 28.08.2024
(51) International Patent Classification (IPC): 
C12N 9/64(2006.01)
A61P 7/02(2006.01)
A61K 38/48(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 7/02; A61K 38/00; C12N 9/6432; C12Y 304/21006
(86) International application number:
PCT/CA2024/051113
(87) International publication number:
WO 2025/043340 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363580012 P

(71) Applicant: Canadian Blood Services
Ottawa, Ontario K1G 4J5 (CA)

(72) Inventor:
  • PRYZDIAL, Ed
    Vancouver, British Columbia V6T 1Z3 (CA)

(74) Representative: Marben S.r.l. 
Via Larga, 16
20122 Milano
20122 Milano (IT)

   


(54) A NON-ENZYMATIC RECOMBINANT LYTIC AGENT